The Nutella approach to innovation is rare in market research. As researchers, we are like magpies, attracted by the latest shiny thing. As an industry, we are constantly looking for the next advance in technology that can help us to gain better insights, in less time, for less money, and rightly so. However, in our pursuit of the latest shiny thing, many fantastic approaches remain under-used and under-innovated.

In this article, Guy Pascoe explores the pros and occasional cons of using web platforms to replace good old TDIs. Most of us who worked in market research in recent years will be familiar with video interviewing, and likely have moderated / watched / taken part in online IDIs or even groups. 

“Telehealth use began to skyrocket back in March as patients saw virtual care as a necessity amid the COVID-19 pandemic. Patients are continuing to see doctors over video visits but for different reasons now: It's more convenient and faster than going to see the doctor in person.” Fierce Healthcare – June 2020

COVID-19 has reminded us how important it is to be able to adapt ourselves to a rapidly changing business environment. Agility is a key element in gaining strategic advantage and market success, both for you as a provider of healthcare products and solutions and for us as your research partner.

When the date of application of the new Medical Devices Regulation (MDR) was postponed by one year, you may have taken a huge sigh of relief. The extra year meant that you could relax, focus on the more urgent tasks, and put your EU-MDR work off for a while.

Stephen Potts recently joined the Purdie Pascoe team as a director. ‘PersPectives’ caught up with Stephen to ask him why he chose our wonderful agency for his next career move and what he thinks he can add to the business.

In order to limit COVID-19 transfer, we are all working from home. Fieldwork progress on current projects has been unaffected although we are monitoring the situation closely. We are confident that we can continue to deliver the same quality and integrity you expect throughout this unusual period.

The date is set! Will you be EU MDR compliant by the 26th May 2020? This is the date by which the EU’s Medical Device Regulations (EU MDR) will require manufacturers to adhere to new, stricter regulations to ensure that their devices are safe to use and allow them to be sold across Europe.

Over the past two months, pharmaceutical companies have donated funds, human resources, intellectual property and manufacturing capacity to the global fight against COVID-19. We at Purdie Pascoe would like to celebrate some of the great initiatives and collaborations that have been launched.

Earlier this month the EU commission announced that the date of application of the new Medical Devices Regulation (MDR) will be postponed by one year, to 26th May 2021, in order to allow members to prioritise the fight against coronavirus.

Social distancing has caused us, as an industry, to change our ways of working and assess how we can continue to deliver essential insights to our businesses. Market research online communities (MROCs) allow us to continue to connect with your customers and deliver the insights you need at this time.

The majority of healthcare respondents like to think of themselves as rational, logical, scientific people who carefully evaluate the benefits and drawbacks of individual products in order to arrive at their prescribing preferences. 

Purdie Pascoe is fully equipped to address and unearth some of the most complex and diverse issues in modern cancer drug development and lifecycle management.

There are over 300 million people living with a rare disease across the globe, and they need help. Purdie Pascoe is dedicated to partnering with life science companies to make timely, informed decisions, and help improve the lives of those affected by rare diseases worldwide.